These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34078439)

  • 21. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
    Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
    Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
    Chen Z; Xiao Z; Zeng S; Yan Z
    Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
    Gong G; Lin T; Yuan Y
    J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer.
    Gong C; Fan Y; Zhou X; Lai S; Wang L; Liu J
    J Cancer; 2021; 12(13):3862-3876. PubMed ID: 34093794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.
    Zhou Q; Mei YD; Yang HJ; Tao YL
    Future Oncol; 2021 May; 17(15):1889-1906. PubMed ID: 33728938
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.
    Cao T; Pan W; Sun X; Shen H
    J Ovarian Res; 2019 Oct; 12(1):101. PubMed ID: 31656201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
    Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
    Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
    Zhou Q; Yang HJ; Zuo MZ; Tao YL
    J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.
    Sun T; Bi F; Liu Z; Yang Q
    Aging (Albany NY); 2020 Jul; 12(13):13281-13296. PubMed ID: 32647070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
    Zhao J; Gao H; He Y
    Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.